Clinical Trial: Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary:
Iodine therapy is the best treatment for graves disease.Most patients receive methimozale prior to radio-iodine treatment. This may decrease treatment response to iodine therapy.
Some physicians advice to discontinue methimazole 3 days before radioiodine therapy and others prefer longer off - methimazole period which bothers most patients. This study aimed to evaluate optimum time for methimazole discontinuation in graves disease.
Detailed Summary:
Sponsor: Mashhad University of Medical Sciences
Current Primary Outcome: thyroid function tests over one year after radioiodine therapy [ Time Frame: months 1 , 3 ,6,9,12 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mashhad University of Medical Sciences
Dates:
Date Received: March 1, 2012
Date Started: February 2010
Date Completion:
Last Updated: March 20, 2012
Last Verified: March 2012